| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |